NCT04874870View on ClinicalTrials.gov

Effectiveness of Splinting After Collagenase Injection

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Dupuytren ContractureDupuytren's Disease
Interventions
DRUG

Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex]

1 injection of 0.58mg will be injected into applicable cord.

COMBINATION_PRODUCT

Xiaflex + Hand-Based Custom Orthosis

1 injection of 0.58mg will be injected into applicable cord followed by use of hand-based custom orthosis to maintain finger extension

Trial Locations (1)

33637

Florida Orthopaedic Institute, Tampa

All Listed Sponsors
collaborator

Endo, Inc.

UNKNOWN

lead

Foundation for Orthopaedic Research and Education

OTHER